Mark Bradley Wilson, Partner at Fulbright & Jaworski LLP will chair 2 linked panel discussions on creative solutions to dealmaking problems and on how to best apply strategic alliance management.
Emerge and happen: creative solutions to difficult problems in dealmaking, on December 3rd, 11am
That things can go wrong in negotiations and partnership is not surprising. However, when you encounter these problems, sometimes creative solutions are needed in order to finally create a mutually beneficial partnership. During this interactive session, the panelists will discuss the common and no so common pitfalls in partnering and negotiations, as well as share their experience on the different stages of negotiations, the difficulties they ran into and the solutions they found.
Make it work and last: how to best apply strategic alliance management, on December 3rd, 2pm
The deal signature is just the beginning of a long road to travel for putting in place a successful partnership. The alliance management is an important piece of the puzzle and if well implemented and understood by both parties, it becomes an effective and invaluable tool in the management of the deal. Let’s discuss how to set it correctly on paper and how to identify the right key licensing terms to the deal and how to manage the partnership in an efficient and rewarding way for both parties.Come meet our speakers of these 2 sessions:
- Stepan LENSKY, Head Strategic Transactions & Alliance Management, BOEHRINGER INGELHEIM
- Juergen WALKENHORST, Head of Life Sciences, PROVENDIS GMBH
- Pascale REDIG, Senior Manager Research & Academic Partnerships / Member of ASTP-Proton Professional Development Committee, JANSSEN PHARMACEUTICA / ASTP PROTON
Mark B. WILSON’s biography
Mark Wilson is a partner in Austin, where his practice focuses on all aspects of patent prosecution and enforcement.
Mark’s docket is split among patent counseling, patent prosecution and patent litigation matters, with an emphasis in biotechnology related matters. Mr. Wilson has significant experience in the areas of genetic engineering, gene therapy, molecular biotechnology assays, chemotherapy, drug screening and targeting, animal and plant breeding programs, biomass production, renewable energy, clean energy technologies, organic chemistry, pharmaceutical development and medical devices.
Mark counsels clients regarding intellectual property portfolio development, management and commercialization on a global scale. He is experienced in technology transfer, including both licensing and company formation and funding. Mr. Wilson drafts and reviews licensing, confidentiality and material transfer agreements. He also prepares pre-litigation, infringement, validity, patentability and freedom-to-operate opinions and provides due diligence review of intellectual property to companies and investors.
Mark’s patent prosecution practice includes all aspects of drafting and prosecuting patent applications before the United States Patent and Trademark Office. He also supervises the prosecution of patent applications before many foreign patent offices. In addition, Mr. Wilson is experienced in appeal and interference practice before the Board of Patent Appeals and Interferences.
Mark’s litigation experience includes all phases of discovery and trial in federal district courts, including investigation and formulation of litigation strategy, motion practice, depositions, preparation and examination of witnesses, trials and evidentiary hearings. He has experience in briefing and the development of appellate strategy before the Court of Appeals for the Federal Circuit.
Mark is involved in a wide variety of professional activities. In 2012, he was elected as Deputy Secretary General of FICPI (Federation Internationale des Conseils en Propriete Industrielle), having previously served FICPI as the Assistant Reporter General of the CET. Mark is a frequent presenter at FICPI events and participant in FICPI delegations, visiting government IP offices around the world.
